Journal of Immunology Research

Cancer Immunology and Cancer Immunodiagnosis 2016


Publishing date
15 Jul 2016
Status
Published
Submission deadline
26 Feb 2016

Lead Editor
Guest Editors

1University of Texas at El Paso, El Paso, USA

2Northwestern University Feinberg School of Medicine, Chicago, USA

3The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China


Cancer Immunology and Cancer Immunodiagnosis 2016

Description

Cancer immunology is the study of interactions between the immune system and cancer cells, which is a growing field of research that aims to identify biomarkers in cancer immunodiagnosis and to discover innovative cancer immunotherapies. The immune response, including the recognition of cancer-specific antigens, is of particular interest in cancer immunology field as the knowledge gained drives the development of new vaccines and antibody therapies. It is also well demonstrated that the immune system can recognize the antigenic changes in cancer cell and further develop antibody against these cellular antigens that have been generally called tumor-associated antigens (TAAs). These cancer-associated autoantibodies might be considered as “reporters” from the immune system to identify the antigenic changes in cellular proteins involved in the transformation process. There has been a growing interest in using serum autoantibodies against TAAs as biomarkers in cancer immunodiagnosis. The persistence and stability of these antibodies in the serum of cancer patients are an advantage over other potential markers, including the TAAs themselves, some of which are released by tumors but rapidly are degraded or cleared after circulating in the serum for a limited time. The key to cancer immunodiagnosis and immunotherapy is an improved understanding of the immune response during malignant transformation.

We invite investigators to contribute original research articles as well as review articles related to cancer immunology. We are particularly interested in articles describing cancer immunodiagnosis and cancer immunotherapy. Both laboratory and clinical studies are welcome.

Potential topics include, but are not limited to:

  • Recent advances in cancer immunology, cancer immunodiagnosis, and cancer immunotherapy
  • Evaluation and validation of TAAs and anti-TAAs as biomarkers in cancer immunodiagnosis
  • Identification and characterization of tumor antigens as potential candidates in cancer vaccine development or as potential targets in cancer immunotherapy
  • Basic studies of tumor antigens involved in tumorigenesis
  • Clinical studies with relevance to cancer immunology and immunodiagnosis

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 9127382
  • - Editorial

Cancer Immunology and Cancer Immunodiagnosis 2016

Jianying Zhang | Bin Zhang | Yi Zhang
  • Special Issue
  • - Volume 2016
  • - Article ID 4757405
  • - Clinical Study

Crucial Contributions by T Lymphocytes (Effector, Regulatory, and Checkpoint Inhibitor) and Cytokines (TH1, TH2, and TH17) to a Pathological Complete Response Induced by Neoadjuvant Chemotherapy in Women with Breast Cancer

Viriya Kaewkangsadan | Chandan Verma | ... | Oleg Eremin
  • Special Issue
  • - Volume 2016
  • - Article ID 7828916
  • - Research Article

Downregulation of p70S6K Enhances Cell Sensitivity to Rapamycin in Esophageal Squamous Cell Carcinoma

Zhaoming Lu | Kezheng Peng | ... | Guiqin Hou
  • Special Issue
  • - Volume 2016
  • - Article ID 8605134
  • - Review Article

Immune Regulation and Antitumor Effect of TIM-1

Peng Du | Ruihua Xiong | ... | Jingting Jiang
  • Special Issue
  • - Volume 2016
  • - Article ID 7128702
  • - Review Article

Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors

Hongyan Qian | Jingxiu Xuan | ... | Guixiu Shi
  • Special Issue
  • - Volume 2016
  • - Article ID 8941260
  • - Review Article

Effector, Memory, and Dysfunctional CD8+ T Cell Fates in the Antitumor Immune Response

John Reiser | Arnob Banerjee
  • Special Issue
  • - Volume 2016
  • - Article ID 8121985
  • - Clinical Study

Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade

Michal Lotem | Sharon Merims | ... | Tamar Peretz
  • Special Issue
  • - Volume 2016
  • - Article ID 6837241
  • - Clinical Study

Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients

Lei Qian | Nanya Wang | ... | Jiuwei Cui
  • Special Issue
  • - Volume 2016
  • - Article ID 3850839
  • - Review Article

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Yelei Guo | Yao Wang | Weidong Han
Journal of Immunology Research
 Journal metrics
Acceptance rate45%
Submission to final decision61 days
Acceptance to publication37 days
CiteScore5.100
Impact Factor3.327
 Submit